Peer-reviewed veterinary case report
Treating drug-resistant wound infections in Arabian horses
By Khalid, Esraa et al.·Published in Frontiers in veterinary science·2025·Department of Microbiology·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Controlling drug-resistant bacteria in Arabian horses: bacteriophage cocktails for treating wound infections.
- Species:
- horse
Plain-English summary
A group of Arabian horses with infected wounds were treated with a combination of bacteriophage therapy and gentamicin, an antibiotic. The horses had severe bacterial infections that were resistant to many common antibiotics, making treatment difficult. The bacteriophages, which are viruses that target bacteria, helped improve wound healing significantly when used alongside gentamicin. The results showed that the horses' wounds closed better and faster with this combined treatment compared to using gentamicin alone. This approach offers hope for managing tough infections in horses that don't respond to traditional antibiotics.
People also search for: Arabian horse wound infection treatment · bacteriophage therapy for horses · antibiotic-resistant bacteria in horses
Abstract
Antimicrobial resistance is a major global health issue requiring a coordinated response. This study investigated for the first time the prevalence, antimicrobial resistance phenotypes of bacteria causing infections in Arabian horses, and the potential of bacteriophage therapy for wound treatment. One hundred clinical samples from infected Arabian horses, presenting respiratory disorders, diarrhea, abortion, wound, and ocular infection, were examined using direct sample multiplex PCR and phenotypic methods. Antimicrobial susceptibility testing of the recovered isolates was performed using panels of 37 antibiotics and broth microdilution method. Bacteriophages were isolated from horse manure. A bacteriophage cocktail was used for treating infected wounds in Arabian horses.was the most predominant pathogen isolated from respiratory infections (17/29, 58.6%), followed byand(9/29, 31.03%, each), and(7/29, 24.13%).andbiovarwere the most frequently isolated bacteria from pyogenic infections. All isolated bacteria showed resistance to multiple antibiotics.spp. exhibited extensive drug resistance (XDR) with complete resistance to amoxicillin-clavulanic acid, amikacin, kanamycin, streptomycin, and cefotaxime. Allspp. displayed multidrug resistance (MDR) phenotype.isolates were highly resistant to fusidic acid,-lactams, and tetracyclines. Amoxicillin-clavulanic acid, fosfomycin, and cephalosporines were ineffective againstisolates. Ticarcillin, clavulanic acid, and colistin were ineffective againstand. Pan-drug-resistant (PDR)isolate was detected in the infected wound. Two lytic bacteriophages (vB_Pae_LP125 and vB_Pae_LS225) from theandfamilies were isolated from the horse manure. Both phages were stable across various temperatures and pH levels.tests showed significant lytic activity against a wide range of bacterial strains. The DNA genomes of all phages displayed distinctive restriction fragment length polymorphism. A bacteriophage cocktail (vB_Pae_LP125 and vB_Pae_LS225), when combined with gentamicin, improved wound healing in infected horses. There were significant differences ( < 0.05) in the wound closure % among the gentamicin group and phage cocktaoil+gentamicin groups on days 3, 5, 7, 10, and 14. This study highlights the widespread antibiotic resistance in bacteria infecting Arabian horses and posing significant challenges to equine infection management. Bacteriophage therapy shows promise as a potential treatment for wound infections.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41169678/